Fingerprint
Dive into the research topics of 'Health-related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically